9-108906417-T-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_003640.5(ELP1):c.1529A>G(p.Glu510Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,613,976 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E510Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_003640.5 missense
Scores
Clinical Significance
Conservation
Publications
- primary dysautonomiaInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- Riley-Day syndromeInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- medulloblastomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ELP1 | NM_003640.5 | c.1529A>G | p.Glu510Gly | missense_variant | Exon 14 of 37 | ENST00000374647.10 | NP_003631.2 | |
| ELP1 | NM_001318360.2 | c.1187A>G | p.Glu396Gly | missense_variant | Exon 14 of 37 | NP_001305289.1 | ||
| ELP1 | NM_001330749.2 | c.482A>G | p.Glu161Gly | missense_variant | Exon 12 of 35 | NP_001317678.1 | ||
| ELP1 | XM_047423991.1 | c.1529A>G | p.Glu510Gly | missense_variant | Exon 14 of 25 | XP_047279947.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152220Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000398 AC: 10AN: 251344 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461756Hom.: 1 Cov.: 31 AF XY: 0.0000303 AC XY: 22AN XY: 727192 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74358 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:3
This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 510 of the ELP1 protein (p.Glu510Gly). This variant is present in population databases (rs755282356, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with ELP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 526192). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
- -
Familial dysautonomia Uncertain:1
- -
not specified Uncertain:1
The c.1529A>G (p.E510G) alteration is located in exon 14 (coding exon 13) of the IKBKAP gene. This alteration results from a A to G substitution at nucleotide position 1529, causing the glutamic acid (E) at amino acid position 510 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at